Development of the nephrotic syndrome during treatment of Crohn's disease with adalimumab

We report a patient with Crohn's disease who presented with renal insufficiency and the nephrotic syndrome after initiating therapy with adalimumab. Renal biopsy showed stages 2 to 3 membranous glomerulonephritis, and immunostaining showed glomerular deposition of immunoglobulin G and C3. The p...

Full description

Bibliographic Details

Published in:	Journal of clinical gastroenterology Vol. 45; no. 3; p. e30
Main Authors:	Gupta, Alok, Pendyala, Prashant, Arora, Pradeep, Sitrin, Michael D
Format:	Journal Article
Language:	English
Published:	United States 01.03.2011
Subjects:	Adalimumab Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Crohn Disease - complications Crohn Disease - drug therapy Humans Male Middle Aged Nephrotic Syndrome - chemically induced Nephrotic Syndrome - physiopathology
ISSN:	1539-2031, 1539-2031
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!